Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:OWLT
NYSE:OWLTMedical Equipment

Owlet (OWLT): Valuation Check After New 1 Natural Way Partnership Expands BabySat Insurance Access

Owlet (OWLT) is back on traders’ screens after announcing a new DME partnership with 1 Natural Way, opening insurance backed access to its FDA cleared BabySat monitor for higher risk infants nationwide. See our latest analysis for Owlet. The DME deal lands after a busy stretch that included the UK and Ireland rollout of Owlet360 and a recent shelf registration closing. The market seems to be reassessing the story, with the share price at $14.05 and a powerful year to date share price return...
TSX:ERD
TSX:ERDMetals and Mining

Erdene Resource Development (TSX:ERD): Valuation Check After First Gold Pour at Bayan Khundii and Growth Plans

Erdene Resource Development (TSX:ERD) has just hit a key milestone at its Bayan Khundii gold mine in Mongolia, pouring first gold and targeting nameplate production by month end, with 2026 exploration spending set to climb. See our latest analysis for Erdene Resource Development. The latest operational milestones seem to be feeding into the story, with the 1-month share price return of 9.28 percent helping rebuild confidence after a softer quarter. Meanwhile, a 1-year total shareholder return...
NasdaqCM:MDXG
NasdaqCM:MDXGBiotechs

MiMedx (MDXG): Fresh Clinical Evidence Spurs a Closer Look at the Stock’s Valuation and Long-Term Upside Potential

MiMedx Group (MDXG) just added fresh peer reviewed backing for its placental allograft products, with a new Journal of Inflammation study underscoring their immunomodulatory role in complex wound healing and longer term competitive positioning. See our latest analysis for MiMedx Group. Even with this new clinical validation, MiMedx Group’s $7.05 share price sits well below its highs, with a year-to-date share price return of negative 24.03 percent and a powerful three-year total shareholder...
SEHK:512
SEHK:512Pharmaceuticals

Grand Pharmaceutical Group (SEHK:512) Valuation After Phase II Success for Innovative TCM Depression Treatment

Grand Pharmaceutical Group (SEHK:512) just cleared a key hurdle. Its TCM antidepressant candidate GPN01360 hit the primary endpoint in a Phase II trial in China, reinforcing the company’s push into broader chronic disease markets. See our latest analysis for Grand Pharmaceutical Group. The market seems to be taking notice, with the latest 1 day share price return of 2.63 percent lifting Grand Pharmaceutical Group to HK$8.19. Its year to date share price return of 78.04 percent and three year...
SZSE:002033
SZSE:002033Hospitality

Asian Dividend Stocks To Watch In December 2025

As the Bank of Japan raises its benchmark interest rate to a 30-year high and China's economic indicators show mixed signals, investors are closely monitoring how these developments might impact Asian markets. In this environment, dividend stocks can offer a stable income stream, making them an attractive option for those seeking reliable returns amidst fluctuating market conditions.
SEHK:2145
SEHK:2145Personal Products

Asian Growth Companies With High Insider Ownership December 2025

As Asian markets navigate a landscape marked by mixed economic signals and evolving monetary policies, investors are increasingly focusing on companies that demonstrate resilience and growth potential. In this context, stocks with high insider ownership often stand out as they can indicate strong management confidence and alignment with shareholder interests, making them attractive considerations in uncertain times.
SHSE:688502
SHSE:688502Electronic

High Growth Tech Stocks In Asia To Watch December 2025

As the Asian tech market navigates a complex landscape marked by Japan's highest interest rates in three decades and China's mixed economic indicators, investors are keenly observing how these macroeconomic factors may influence the region's high-growth sectors. In such an environment, a good stock often exhibits resilience through robust fundamentals and adaptability to shifting economic conditions, making it well-positioned to capitalize on emerging technological trends.
SZSE:002284
SZSE:002284Auto Components

Undiscovered Gems in Asia to Watch This December 2025

As December 2025 unfolds, the Asian markets are drawing attention amid significant economic shifts, such as the Bank of Japan's interest rate hike to levels not seen in three decades. Against this backdrop, identifying promising small-cap stocks requires a keen eye on companies that can navigate these changing conditions and capitalize on regional growth opportunities.
SZSE:002239
SZSE:002239Auto Components

Rongan PropertyLtd And 2 Other Asian Penny Stocks To Consider

As Asian markets navigate a period of mixed economic signals and monetary policy shifts, investors are increasingly exploring diverse avenues for potential growth. Penny stocks, often associated with smaller or newer companies, represent a unique opportunity within this landscape. Despite their somewhat outdated name, these stocks can still offer significant value when they boast strong financial health and solid fundamentals.
NasdaqGS:GO
NasdaqGS:GOConsumer Retailing

Reassessing Grocery Outlet (GO) Valuation After Analyst Downgrades and Weaker Same-Store Sales

Grocery Outlet Holding (GO) is back in focus after a wave of cautious analyst moves, sparked by weaker November same store sales and a sharp drop in EBT driven purchases among its budget conscious shoppers. See our latest analysis for Grocery Outlet Holding. The stock’s slide has been steady rather than sudden, with a 90 day share price return of minus 35.9 percent and a one year total shareholder return of minus 40.23 percent underscoring that momentum is clearly fading as investors reassess...